Entrusted financial announcement
Release time:
2021-05-20
证券简称:尖峰集团 证券代码:600668 编号:临2020-030
浙江尖峰集团股份有限公司
委托理财公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
重要内容提示:
- 委托理财受托方:广发银行股份有限公司金华分行
- 委托理财金额:10,000万元人民币
- 委托理财产品名称:薪加薪16号XJXCKJ20516
- 委托理财投资类型:保本浮动收益型结构性存款
- 委托理财期限:2020年11月05日—2021年02月03日
- 履行的审议程序:2019年4月26日,公司召开的第十届董事会第10次会议审议通过了《关于授权公司董事长利用自有资金进行委托理财的议案》。授权公司董事长行使不超过人民币5亿元的委托理财的决策权,在该额度内资金可以滚动使用,但任一时点存续的委托理财余额合计不得超过5亿元,每笔委托理财的期限均不得超过12个月。详见本公司在2019年4月30日在上海证券交易所网站等披露的《关于授权公司董事长利用自有资金进行委托理财的公告》(临2019-012)。
一、本次委托理财概况
(一)委托理财目的
公司在不影响主营业务的正常开展、日常运营资金周转需要和资金安全的前提下,使用暂时闲置自有资金10,000万元购买广发银行股份有限公司金华分行发售的“薪加薪16号”XJXCKJ20516 W款人民币结构性存款产品。本产品为保本浮动收益型存款产品,安全性高、流动性好、风险性低。公司通过进行适度的低风险理财产品投资业务,有利于提高资金使用效率,且获得一定的理财收益。
(二)资金来源
本次委托理财的资金来源系公司自有资金。
(三)委托理财产品的基本情况
|
受托方 名称 |
产品 类型 |
产品 名称 |
金额 (万元) |
预计年化 收益率 |
预计收益金额 (万元) |
|
广发银行股份有限公司金华分行 |
银行结构性存款产品 |
薪加薪16号XJXCKJ20516 |
10,000 |
1.50%—3.10% |
36.99-76.44 |
|
产品 期限 |
收益 类型 |
结构化 安排 |
参考年化 收益率 |
预计收益 (万元) |
是否构成 关联交易 |
|
90天 |
保本浮动收益型 |
无 |
1.50%—3.10% |
36.99-76.44 |
否 |
(四)公司对委托理财相关风险的内部控制
1、委托理财情况由公司审计部门进行日常监督,定期对公司委托理财的进展情况、盈亏情况、风险控制情况和资金使用情况进行审计、核实。
2、公司进行委托理财,应当选择资信、财务状况良好、盈利能力强的合格专业理财机构作为受托方,并与受托方签订书面合同,明确委托理财的金额、期间、投资品种、双方的权利义务及法律责任等,必要时要求提供担保。公司董事会指派公司财务负责人跟踪委托理财的进展情况及投资安全状况。财务负责人发现公司委托理财出现异常情况时应当及时向董事会报告,以便董事会立即采取有效措施回收资金,避免或减少公司损失。
3、公司独立董事可以对委托理财情况进行检查。独立董事在公司内部审计核查的基础上,以董事会审计委员会核查为主,必要时由二名以上独立董事提议,有权聘任独立的外部审计机构进行委托理财的专项审计。独立董事应对提交董事会审议的委托理财事项发表独立意见。
4、公司监事会有权对公司委托理财情况进行定期或不定期的检查。如发现违规操作情况可提议召开董事会审议停止公司的相关投资活动。
5、公司委托理财具体执行人员及其他知情人员在相关信息公开披露前不得将公司投资情况透露给其他个人或组织,但法律、法规或规范性文件另有规定的除外。
6、凡违反相关法律法规、本制度及公司其他规定或由于工作不尽职,致使公司遭受损失或收益低于预期,将视具体情况,追究相关人员的责任。
本次公司购买广发银行发行的保本浮动收益型结构性存款,在前述董事会对董事长的授权范围内,该产品风险程度低,符合公司内部资金管理要求。
二、本次委托理财的具体情况
(一)委托理财合同主要条款
客户:浙江尖峰集团股份有限公司
银行:广发银行股份有限公司金华分行
|
产品名称 |
薪加薪16号XJXCKJ20516 |
|
产品代码 |
XJXCKJ20516 |
|
挂钩标的 |
交易日东京时间下午15:00点在彭博页面上“MID”标题下显示的美元兑日元汇率 |
|
产品期限 |
90天 |
|
产品类型 |
保本浮动收益型存款产品 |
|
本金保证 |
银行在本产品到期时保证存款本金 |
|
存款成立日 |
2020年11月05日 |
|
存款到期日 |
2021年02月03日 |
|
提前赎回、终止 |
本结构性存款产品到期日之前,投资者不具有主动申请该产品赎回的权利,即投资者无权单方面主动决定提前赎回本结构性存款产品。在投资者违约赎回的情况下,可能会损失部分本金及收益。 本结构性存款产品到期日之前,除遇法律法规、监管规定出现重大变更,要求本立品终止外,广发银行无权单方面主动决定提前终止本产品。 |
|
本金及收益支付 |
结构性存款到期日,广发银行向投资者归还结构性存款本金和应得的结构性存款收益,该结构性存款本金和结构性存款收益于到期日划转至投资者指定账户。 |
|
投资范围
|
本结构性存款本金部分纳入广发银行资金统一运作管理,投资者的结构性存款收益取决于美元兑日元在观察期内的表现。 |
|
结构性存款收益说明 |
期初价格:期初价格定义为结构性存款启动日当天的定盘价格,本结构性存款计划即为2020年11月05日的定盘价格。 如果在该日挂钩标的发生干扰市场事件或市场特殊事件,则按照对干扰市场事件或市场特殊事件的处理来确定该挂钩标的的期初价格。 期末价格:期末价格定义为结构性存款结算日当天的定盘价格,本结构性存款计划即为2021年02月01日的定盘价格。 如果在该日挂钩标的发生干扰市场事件或市场特殊事件,则按照对干扰市场事件或市场特殊事件的处理来确定该挂钩标的的期末价格。 观察区间上限:期初价格+4.90 观察区间下限:期初价格-4.90 观察期:从结构性存款启动日(含)的东京时间下午15:00起直至结构性存款结算日(含)的东京时间下午15:00止的全部交易日。 有效天数:在观察期的所有交易日中,标的每日收盘价处于观察区间上限和观察区间下限之间(含界限)的天数。 收益率(年化):1.5%+1.60%*有效天数/交易日天数 结构性存款收益率的确定: 结构性存款收益率根据以下公式来确定: 产品观察期间(即起息日至结算日期间投资标的的交易日,含结算日),美元兑日元汇率处于观察区间上限和观察区间下限之间(含界限)的天数为有效天数,收益计算方法为: 1.5%+1.60%*有效天数/交易日天数。 |
|
预期收益计算方法 |
投资者获得的结构性存款收益=结构性存款本金×到期年化收益率×实际结构性存款天数÷365,精确到小数点后2位。
|
(二)委托理财的资金投向
本次公司委托理财的资金投向为广发银行结构性存款产品。
(三)风险控制分析
公司本次使用自有资金购买广发银行金华分行发售的保本浮动收益型结构性存款,在公司第十届董事会第10次会议授权董事长决策范围之内。公司财务部建立台账负责对短期理财产品进行管理,建立健全会计账目,做好资金使用的财务核算工作。公司在本次交易后将履行信息披露义务,并实时跟踪进展情况及时披露。
广发银行结构性存款属于保本浮动收益型产品,广发银行股份有限公司金华分行承诺保障结构性存款本金,因此该产品风险程度较低,符合公司《委托理财管理制度》的要求。
三、委托理财受托方的情况
(一)受托方的基本情况
|
名称 |
成立时间 |
法定代表人 |
注册 资本 (万元) |
主营业务 |
主要股东及实际控制人 |
是否为本次交易专设 |
|
广发银行股份有限公司 |
1988-07-08 |
尹兆君 |
1968719.6272 |
吸收公众存款;发放短期、中期和长期贷款;办理国内外结算;办理票据承兑与贴现;发行金融债券;代理发行、代理兑付、承销政府债券;买卖政府债券、金融债券等有价证券;从事同业拆借;提供信用证服务及担保;从事银行卡业务;代理收付款项及代理保险业务;提供保管箱服务;外汇存、贷款;外汇汇款;外币兑换;国际结算;结汇、售汇;同业外汇拆借;外汇票据的承兑和贴现;外汇借款;外汇担保;买卖和代理买卖股票以外的外币有价证券;发行和代理发行股票以外的外币有价证券;自营和代客外汇买卖;代理国外信用卡的发行及付款业务;离岸金融业务;资信调查、咨询、见证业务;经中国银监会等批准的其他业务。(依法须经批准的项目,经相关部门批准后方可开展经营活动) |
中国人寿保险(集团)公司 |
否 |
(二)受托方最近一年主要财务指标
截至2019年12月31日,广发银行股份有限公司总资产26,327.98亿元,归属于股东的净资产2,095.64亿元;2019年营业收入763.12亿元,归属于股东的净利润125.81亿元。
(三)广发银行股份有限公司与本公司之间在产权、业务、资产、债权债务、人员等方面均不存在关联关系。
四、对公司的影响
(一)本公司最近一年又一期主要财务指标
单位:万元
|
项目 |
2019年12月31日 |
2020年9月30日 |
|
总资产 |
547,517.79 |
610,942.80 |
|
总负债 |
139,487.88 |
157,117.13 |
|
归属于公司股东的净资产 |
378,910.99 |
426,929.92 |
|
|
2019年度 |
2020年1-9月 |
|
经营性现金流量净额 |
51,998.13 |
24,611.67 |
|
营业收入 |
354,753.76 |
224,065.44 |
|
归属于公司股东的净利润 |
72,468.81 |
51,623.07 |
公司本次购买广发银行结构性存款理财产品是在不影响主营业务的正常开展、日常运营资金周转需要和资金安全的前提下,使用短期闲置自有资金进行委托理财业务,有利于提高公司资金使用效率。
(二)截止2020年9月30日,公司货币资金为26,471.11万元,本次购买广发银行结构性存款支付的金额占最近一期期末货币资金的37.78%,对本公司未来主营业务、财务状况、经营成果和现金流量等不会造成重大的影响。
(三)根据企业会计准则第22号—《金融工具确认和计量》规定,该结构性银行存款符合以摊余成本计量的金融资产,列示于资产负债表—其他流动资产,利息收益计入利润表—投资收益。
五、风险提示
尽管本公司购买的结构性存款属于短期保本浮动收益型的低风险理财产品,但金融市场受宏观经济影响较大,不排除该项投资受到市场风险、信用风险、政策风险、流动性风险、不可抗力风险等风险从而影响收益。
六、独立董事意见
公司召开的第十届董事会第10次会议审议通过了《关于授权公司董事长决定委托理财的议案》,独立董事发表了独立意见,认为:该决议的形成符合《公司法》、公司《章程》等有关规定,没有损害中小股东的利益。
七、截至本公告日,公司最近十二个月使用自有资金或募集资金委托理财的情况 单位:万元
|
序号 |
理财产品类型 |
实际投入 金额 |
实际收回 本金 |
实际收益 |
尚未收回 本金金额 |
|
1 |
薪加薪16号人民币结构性存款产品 |
10,000.00 |
10,000.00 |
33.75 |
/ |
|
2 |
渤海银行S191620号结构性存款理财产品 |
5,000.00 |
5,000.00 |
50.49 |
/ |
|
3 |
渤海银行S192012号结构性存款理财产品 |
3,000.00 |
3,000.00 |
29.92 |
/ |
|
4 |
慧盈人民币单位结构性存款产品 |
3,000.00 |
3,000.00 |
29.96 |
/ |
|
5 |
薪加薪16号人民币结构性存款产品 |
5,000.00 |
5,000.00 |
50.55 |
/ |
|
6 |
结构性存款 |
5,000.00 |
5,000.00 |
18.74 |
/ |
|
7 |
慧盈人民币单位结构性存款产品 |
5,000.00 |
5,000.00 |
49.91 |
/ |
|
8 |
薪加薪16号人民币结构性存款产品 |
10,000.00 |
10,000.00 |
100.97 |
/ |
|
9 |
慧盈人民币单位结构性存款产品 |
10,000.00 |
10,000.00 |
100.82 |
/ |
|
10 |
慧盈人民币单位结构性存款产品 |
10,000.00 |
10,000.00 |
92.66 |
/ |
|
11 |
薪加薪16号人民币结构性存款产品 |
5,000.00 |
5,000.00 |
42.67 |
/ |
|
12 |
慧盈人民币单位结构性存款产品 |
10,000.00 |
10,000.00 |
79.59 |
/ |
|
13 |
薪加薪16号人民币结构性存款产品 |
15,000.00 |
/ |
/ |
15,000.00 |
|
14 |
慧盈人民币单位结构性存款产品 |
10,000.00 |
10,000.00 |
39.07 |
/ |
|
15 |
汇利丰2020年6156期对公定制人民币结构性存款产品 |
7,000.00 |
/ |
/ |
7,000.00 |
|
16 |
薪加薪16号人民币结构性存款产品 |
5,000.00 |
/ |
/ |
5,000.00 |
|
17 |
招商银行结构性存款NHZ00043 |
5,000.00 |
/ |
/ |
5,000.00 |
|
18 |
薪加薪16号人民币结构性存款产品 |
10,000.00 |
/ |
/ |
10,000.00 |
|
合计 |
133,000.00 |
91,000.00 |
719.10 |
42,000.00 |
|
|
最近12个月内单日最高投入金额 |
50,000.00 |
||||
|
最近12个月内单日最高投入金额/最近一年净资产(%) |
13.20 |
||||
|
最近12个月委托理财累计收益/最近一年净利润(%) |
0.99 |
||||
|
目前已使用的理财额度 |
42,000.00 |
||||
|
尚未使用的理财额度 |
8,000.00 |
||||
|
总理财额度 |
50,000.00 |
||||
特此公告
浙江尖峰集团股份有限公司
董事会
二〇二〇年十一月六日
More information
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-31
Jianfeng Pharmaceutical Artificial Niuhuang Project Starts
News from this newspaper Jianfeng Pharmaceutical artificial bezoar technical transformation project recently started construction in Qiubin Factory. Artificial bezoar has the effect of clearing away heat and detoxification, resolving phlegm, and is commonly used in Chinese and Western medicines such as colds, clearing away heat and detoxification. As the vast majority of artificial bezoar-related preparations are national essential drugs, with the further implementation of the medical reform policy, the downstream industry of artificial bezoar will enter a new round of business cycle. Jianfeng Pharmaceutical has many years of experience in artificial bezoar production. The technological transformation project will use the existing workshop structure, public works and operators of Qiubin Factory to achieve an annual production capacity of 100 tons of artificial bezoar by adding production equipment such as double cone rotary vacuum drying, horizontal ball mill pulverizer unit, hopper and hoist, closed screening system, and upgrading some public systems. According to the project implementation plan, the project will complete the civil engineering in May. Complete the commissioning, testing and verification of equipment and facilities in July, with trial production conditions; Strive to complete the on-site inspection of GMP certification before the end of December. At present, the factory buildings in Qiubin are vacated and the site is cleaned up. It is understood that the production of natural bezoar is very small, the price is extremely high, and the market rarely provides it. As a biochemical API, artificial bezoar has fewer manufacturers. In the past, due to relatively loose supervision, the testing methods of raw materials and finished products are relatively simple, the quality control indicators are not perfect, and the quality of products on the market is uneven. It is imperative to improve the quality standards. To this end, the State Food and Drug Administration issued the "Biochemical Drug GMP Quality Management Practice (Draft for Comment)" at the end of 2016, which was implemented in March 2017. spike medicine
2020
07-31
Recently, Jianfeng Health has been awarded a number of plaques and certificates by the Department of Science and Technology of Zhejiang Province, the people's Government of Jinhua City, and the Science and Technology Bureau of Jinhua City. They are "Zhejiang Science and Technology small and medium-sized Enterprises", "Jinhua High-tech Enterprises", "Jinhua Agricultural Science and Technology Enterprises", "Jinhua Agricultural Science and Technology Research and Development Center" and so on. According to the relevant requirements, Zhejiang science and technology-based small and medium-sized enterprises must be small and medium-sized enterprises with independent intellectual property rights, proprietary technology or advanced knowledge, engaged in the research, development, production, sales and service of high-tech and its products, and the proportion of enterprises engaged in scientific and technological research and development personnel accounting for no less than 10% of the total number of employees in that year. Since its establishment, Jianfeng Health has attached great importance to the training of scientific and technological personnel, paid attention to the application of its own intellectual property rights, paid attention to product research and development and the protection of intellectual property rights, promoted the application of intellectual property rights, and encouraged employees to invent and create. By the end of 2016, a total of 8 invention patents and 5 appearance patents had been applied, and 1 invention patent and 5 appearance patents had been obtained. High-tech enterprises in Jinhua City must meet the requirements of the ''High-tech Fields Supported by the State, ''and continue to carry out research and development and technological achievements transformation. Their main products (services) have independent intellectual property rights (authorized, registered or accepted). There are certain requirements for the proportion of R & D personnel, the proportion of R & D funds and the income of high-tech products. The acquisition of high-tech enterprises in Jinhua City has laid the foundation for the further declaration of national high-tech enterprises in the future. In the identification of agricultural science and technology enterprises in Jinhua City, the field of peak health technology belongs to the deep processing technology and equipment of agricultural products, Chinese herbal pieces and plant extracts.
2020
07-31
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-30
Peak Pharmaceutical was rated as a national intellectual property advantage enterprises
The score ranked first among Jinhua participating enterprises. A few days ago, Peak Pharmaceutical Company was rated as a national intellectual property advantage enterprise. The selection of national intellectual property advantage enterprises is organized by the State Intellectual Property Office. The purpose is to accelerate the formation of a group of Chinese intellectual property leading enterprises with independent intellectual property rights, well-known brands and international competitive advantages, and achieve the development goal of strong intellectual property enterprises. Since Jianfeng Pharmaceutical introduced the GB-T29490-2013 "Enterprise Intellectual Property Management Standard" in 2013, it has been rated as a patent demonstration enterprise in Zhejiang Province in 2013. In 2014, the "Jianfeng" trademark obtained a famous trademark in Zhejiang Province, and the first edition of the "Intellectual Property Manual" was compiled and implemented in 2015. In 2016, it passed the third-party certification of the GB-T29490-2013 "Enterprise Intellectual Property Management Standard". The "Jianfeng" trademark was rated as a well-known trademark by the State Administration of China. In the application and selection of national knowledge by superior enterprises, 52 enterprises in Zhejiang Province won this honor, ranking second in the country in number; Jianfeng Pharmaceutical ranked first among Jinhua participating enterprises. (Zhang Mingyin)
2020
07-31
Group Party Committee to determine the annual work plan
The party Committee of the group company has determined its work ideas and work plan for 2017 a few days ago, and relevant work has been arranged below. In view of the current new political and economic situation and the task of enterprise transformation and development, the general requirements of the Party Committee of the Group Company for 2017 are: to thoroughly study and implement the spirit of the Sixth Plenary Session of the 18th CPC Central Committee and the series of important speeches by General Secretary Xi Jinping, the spirit of the Seventh Party Congress of Jinhua City, to closely revolve around the center of enterprise production, operation and reform and development, and to adhere to scientific development and cross-regional development as the first priority, in order to continue to carry out the study and education of "five stars striving for innovation" and "two learning and one doing", we should highlight the main line of comprehensively and strictly administering the party according to the rules, firmly establish the political consciousness, overall situation consciousness, core consciousness and alignment consciousness of the majority of Party members and cadres, strengthen and improve the party building work in enterprises in the spirit of reform, and strive to improve the scientific, standardized and institutionalized level of Party building work in enterprises, in order to promote the scientific development of the group company, leapfrog development and harmonious development, it provides a strong political, ideological and organizational guarantee. The working idea of the Party Committee of the Group Company in 2017 is to focus on "one center", adhere to "one concept", highlight "three key points" and do a good job in "three constructions". That is: centering on the "one center" of enterprise production, operation and reform and development, we should strive to strengthen the "one concept" of "the organic unity of the party's leadership and the improvement of corporate governance"; to "thoroughly implement the main responsibility of the party committee; continue to carry out the study and education of" two learning and one doing "; and improve the system of party building work" as the "three key points", and focus on "team building and team building
2020
07-31